Suchergebnisse - "Remsing Rix, Lily L"

PubPharm (28)

1

Differential network analysis of ROS1 inhibitors reveals lorlatinib polypharmacology through co-targeting PYK2

enthalten in: Cell chemical biology | 2024

von Liao, Y. | Remsing Rix, L. | Li, X. | +8

2

IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells

enthalten in: Science signaling | 2022

von Remsing Rix, L. | Sumi, N. | Hu, Q. | +14

3

Turning liabilities into opportunities : Off-target based drug repurposing in cancer

enthalten in: Seminars in cancer biology | 2021

von Palve, V. | Liao, Y. | Remsing Rix, L. | +1

4

Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model

enthalten in: FEBS open bio | 2019

von Sarcar, B. | Gimbrone, N. | Wright, G. | +8

5

Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets

enthalten in: Cell chemical biology | 2019

von Sumi, N. | Ctortecka, C. | Hu, Q. | +11

6

Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia

enthalten in: Scientific reports | 2019

von Kuenzi, B. | Remsing Rix, L. | Kinose, F. | +4

7

Characterization of epidermal growth factor receptor ( EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model

enthalten in: FEBS Open Bio | 2019

von Sarcar, B. | Gimbrone, N. | Wright, G. | +8

8

Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells

enthalten in: Molecular & cellular proteomics : MCP | 2018

von Ctortecka, C. | Palve, V. | Kuenzi, B. | +9

9

Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9 inhibition

enthalten in: Molecular oncology | 2018

von Phadke, M. | Remsing Rix, L. | Smalley, I. | +7

10

Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition

enthalten in: Molecular Oncology | 2018

von Phadke, M. | Remsing Rix, L. | Smalley, I. | +7